The overexpression of FERMT1 was found in multiple tumors such as colon cancer, gastric cancer, oral squamous cell carcinoma, and nasopharyngeal carcinoma, and has been associated with metastasis and poor prognosis [9,10,11,12]. Here, FERMT1 is linked to nasopharyngeal carcinoma.